Scientists comment on the FDA approving Cobenfy (KarXT) for schizophrenia. Dr Sameer Jauhar, Senior Clinical Lecturer in Affective Disorders and Psychosis, Consultant Psychiatrist, King’s College, ...

September 26, 2024 expert reaction to modelling study looking at whether protection against measles from the MMR vaccine decreases over time . A modelling study published in the L ...

The vast majority of cases of measles in England are in unvaccinated children and young people and outbreaks are always driven by low vaccine coverage, but the proportion of measles cases in adults ...

Data published by the World Health Organisation looks at adolescent social media use and gaming. Prof Ben Carter, Professor of Medical Statistics, Institute of Psychiatry, Psychology & Neuroscience at ...

Parkinson’s is the fastest growing neurological condition in the world, affecting around 153,000 people in the UK. It affects the dopamine-producing neurons in the brain and leads to many symptoms, ...

A follow up of a phase 2 trial published in eClinicalMedicine looks at the effect of psilocybin versus escitalopram for depression. Dr James Rucker, Consultant Psychiatrist & Senior Clinical Lecturer ...

Scientists comment on the new COVID-19 variant, XEC. Prof Francois Balloux, Professor of Computational Systems Biology and Director, UCL Genetics Institute, UCL, said: What is XEC?

Rapid Reactions: responding to breaking news. The demands of the 24-hour media machine mean that news journalists often don’t have the luxury of time to track down the best scientists when a science ...

“The paper by Crits-Christoph and others is a high quality set of studies, representing a detailed analysis of a major public dataset, released earlier this year by Chinese workers. The conclusions in ...

‘Comparative effects of drug interventions for the acute management of migraine episodes in adults: systematic review and network meta-analysis’ by William K Karlsson et al. was published in The BMJ ...